Biblio

Filters: Author is Zhang, Xiao-Hui [Clear All Filters]

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

A

Tang F-F, Huang X-J, Zhang X-H, Chen H, Chen Y-H, Han W, Chen Y, Wang F-R, Wang Y, Wang J-Z, et al. Allogeneic hematopoietic cell transplantation for adult patients with treatment-related acute myeloid leukemia during first remission: Comparable to de novo acute myeloid leukemia. Leuk Res. 2016;47:8-15.

Xu L-P, Xu Z-L, Zhang X-H, Chen H, Chen Y-H, Han W, Chen Y, Wang F-R, Wang J-Z, Wang Y, et al. Allogeneic Stem Cell Transplantation for Patients with T315I BCR-ABL Mutated Chronic Myeloid Leukemia. Biol Blood Marrow Transplant. 2016.

Han X-H, Wang C-L, Xie Y, Ma J, Zhang X-H, Hu Q-W, Lin G, Liu S, Lu J-G. Anti-metastatic effect and mechanisms of Wenshen Zhuanggu formula in Human breast Cancer cells. J Ethnopharmacol. 2014.

Shi M-M, Kong Y, Song Y, Sun Y-Q, Wang Y, Zhang X-H, Xu L-P, Liu K-Y, Huang X-J. Atorvastatin enhances endothelial cell function in post transplant poor graft function. Blood. 2016.

C

Tang F-F, Cheng Y-F, Xu L-P, Zhang X-H, Yan C-H, Han W, Chen Y-H, Huang X-J, Wang Y. cGVHD in pediatric haplo-HSCT. Biol Blood Marrow Transplant. 2020.

Ma R, Huang X-J, Xu L-P, Liu K-Y, Zhang X-H, Yan C-H, Han W, Wang F-R, Chen Y-H, Chen H, et al. Comparable Outcomes after Hematopoietic Stem Cell Transplantation from Mother Donors and Matched Unrelated Donors in Patients with Hematopoietic Malignancies. Biol Blood Marrow Transplant. 2019.

Mo X-D, Zhang X-H, Xu L-P, Wang Y, Yan C-H, Chen H, Chen Y-H, Han W, Wang F-R, Wang J-Z, et al. Corrigendum to 'Interferon α: A potentially effective treatment for minimal residual disease in acute leukemia/myelodysplastic syndrome after allogeneic hematopoietic stem cell transplantation' [Biology of Blood and Marrow Transplantation 21/11 (2015) 19. Biol Blood Marrow Transplant. 2019.

Mo X-D, Zhang X-H, Xu L-P, Wang Y, Yan C-H, Chen H, Chen Y-H, Han W, Wang F-R, Wang J-Z, et al. Corrigendum to 'Interferon-α is effective for treatment of minimal residual disease in patients with acute leukemia after allogeneic hematopoietic stem cell transplantation: results of a registry study' [Biology of Blood and Marrow Transplantation 23/8 (. Biol Blood Marrow Transplant. 2019.

Yan C-H, Liu Q-F, Wu D-P, Zhang X, Xu L-P, Zhang X-H, Wang Y, Huang H, Bai H, Huang F, et al. Corrigendum to 'Prophylactic donor lymphocyte infusion (DLI) followed by minimal residual disease and graft-versus host disease guided multiple DLIs could improve outcomes after allogeneic hematopoietic stem cell transplantation in patients with refractor. Biol Blood Marrow Transplant. 2019.

D

Jin Y-H, Hua Q-F, Zheng J-J, Ma X-H, Chen T-X, Zhang S, Chen B, Dai Q, Zhang X-H. Diagnostic Value of ER, PR, FR and HER-2-Targeted Molecular Probes for Magnetic Resonance Imaging in Patients with Breast Cancer. Cell Physiol Biochem. 2018;49(1):271-281.

Zhao X-Y, Yu X-X, Xu Z-L, Cao X-H, Huo M-R, Zhao X-S, Chang Y-J, Wang Y, Zhang X-H, Xu L-P, et al. Donor and host coexpressing KIR ligands promote NK education after allogeneic hematopoietic stem cell transplantation. Blood Adv. 2019;3(24):4312-4325.

Zhang J-M, Xu Y, Gale RP, Wu L-X, Zhang J, Feng Y-H, Qin Y-Z, Jiang H, Jiang Q, Jiang B, et al. DPEP1 expression promotes proliferation and survival of leukaemia cells and correlates with relapse in adults with common B cell acute lymphoblastic leukaemia. Br J Haematol. 2020.

Song Y, Zhao H-Y, Lyu Z-S, Cao X-N, Shi M-M, Wen Q-, Tang F-F, Wang Y, Xu L-P, Zhang X-H, et al. Dysfunctional bone marrow mesenchymal stem cells in patients with poor graft function after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2018.

E

Chang Y-J, Xu L-P, Wang Y, Zhang X-H, Chen H, Chen Y-H, Wang F-R, Han W, Sun Y-Q, Yan C-H, et al. Effects of low-dose glucocorticoid prophylaxis on chronic GVHD and GVHD-free, relapse-free survival after haploidentical transplantation: long-term follow-up of a controlled, randomized open-label trial. Biol Blood Marrow Transplant. 2018.

F

Guo Z-P, Wang T, Xu L-P, Zhang X-H, Wang Y, Huang X-J, Chang Y-J. Factors affecting the CD34(+) cell yields from the second donations of healthy donors: The steady-state lymphocyte count is a good predictive factor. Transfus Apher Sci. 2016.

Chen Y, Huang X-J, Wang Y, Liu K-Y, Chen H, Chen Y-H, Zhang X-H, Wang F-R, Han W, Wang J-Z, et al. Febrile reaction associated with the infusion of haploidentical peripheral blood stem cells: incidence, clinical features, and risk factors. Transfusion. 2015.

Zhao X-Y, Pei X-Y, Chang Y-J, Yu X-X, Xu L-P, Wang Y, Zhang X-H, Liu K-Y, Huang X-J. First-line therapy with donor-derived HCMV-specific T cells reduces persistent HCMV infection by promoting antiviral immunity after allogenic stem cell transplantation. Clin Infect Dis. 2019.

Zhang Y-Y, Mo X-D, Zhang X-H, Xu L-P, Wang Y, Yan C-H, Chen H, Chen Y-H, Han W, Wang F-R, et al. FLT3 internal tandem duplication does not impact prognosis after haploidentical allogeneic hematopoietic stem cell transplantation in AML patients. Bone Marrow Transplant. 2019.

Zeng Q-Z, Zhang Y-Y, Wu Y-J, Zhang Z-Y, Zhang J-N, Fu H-X, Wang J-Z, Wang F-R, Yan C-H, Mo X-D, et al. Frequency, risk factors and outcome of active tuberculosis following allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2020.

G

Wen Q, Kong Y, Zhao H-Y, Zhang Y-Y, Han T-T, Wang Y, Xu L-P, Zhang X-H, Huang X-J. G-CSF-induced macrophage polarization and mobilization may prevent acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant. 2019.

I

Liu J, Gao H, Xu L-P, Mo X-D, Liu R, Liang S, Wu N, Wang M, Wang Z, Chang Y-J, et al. Immunosuppressant indulges EBV reactivation and related lymphoproliferative disease by inhibiting Vδ2 T cells activities after hematopoietic transplantation for blood malignancies. J Immunother Cancer. 2020;8(1).

Xu Z-L, Cheng Y-F, Zhang Y-Y, Mo X-D, Han T-T, Wang F-R, Yan C-H, Sun Y-Q, Chen Y-H, Tang F-F, et al. The incidence, clinical outcome and protective factors of mixed chimerism following hematopoietic stem cell transplantation for severe aplastic anemia. Clin Transplant. 2020:e14160.

Tang F-F, Cheng Y-F, Xu L-P, Zhang X-H, Yan C-H, Han W, Chen Y-H, Huang X-J, Wang Y. The incidence, risk factors, and outcomes of acute graft-vs-host disease in pediatric T-cell-replete haploidentical hematopoietic stem cell transplantation. Pediatr Transplant. 2020:e13793.

Pages